Safety of house dust mite subcutaneous immunotherapy in preschool children with respiratory allergic diseases

BACKGROUND: Allergen immunotherapy (AIT) is the only causal therapy for IgE-mediated allergy. There is less evidence about the safety and efficacy of AIT especially subcutaneous immunotherapy (SCIT) in children under 5 years old. We aimed to investigate the side effects and associated risk factors o...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yaqi, Ma, Dongxia, Huang, Nan, Li, Wenjing, Jiang, Qing, Wang, Yin, Wang, Xiaolong, Yang, Lin, Zhu, Rongfei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8063484/
https://www.ncbi.nlm.nih.gov/pubmed/33892756
http://dx.doi.org/10.1186/s13052-021-01046-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8063484/
https://www.ncbi.nlm.nih.gov/pubmed/33892756
http://dx.doi.org/10.1186/s13052-021-01046-z

Ejemplares similares